Presentation Information
[SY-101-01]Quality of Life and Body Image in Skin Diseases
*Yuko Higaki (Wakamatsucho Mental and Skin Clinic(Japan))
Keywords:
Psychodermatology,Quality of Life,Body Image
The skin, as an interface with the external environment, is influenced by factors like cosmetics, UV rays, and physical behaviors. Visible skin lesions impact patients' body image and social lives, serving as significant negative contributors to their quality of life (QOL).
QOL is measured using tools such as the Dermatology Life Quality Index (DLQI), Skindex, and Psoriasis Disability Index (PDI). Cross-sectional studies with these tools have revealed the substantial burden of dermatological diseases on patients.
Recently, a research group, including the presenter, conducted a qualitative study examining the burden of psoriasis with visible lesions. The study highlighted difficulties in social activities and major life decisions, deeply affecting patients' lives. Based on these findings, the team plans to develop a new QOL tool for quantitative research.
Skin conditions also affect the QOL of patients' families. Though the Family Dermatology Life Quality Index (FDLQI) is available in Japanese, research in this area is limited but expected to advance.
Body image evaluations using the Japanese Cutaneous Body Image Scale (CBIS) showed consistently low scores among female patients with various skin diseases. Notable declines were found in atopic dermatitis, seborrheic dermatitis, and diffuse alopecia. Among atopic dermatitis patients, female scores were lower than male, correlating with emotional impacts on QOL.
Evaluating QOL is essential in both cross-sectional research and intervention outcomes like drug therapies. Using simple questionnaires in routine practice helps healthcare providers understand patient concerns, fostering stronger trust in doctor-patient relationships.
QOL is measured using tools such as the Dermatology Life Quality Index (DLQI), Skindex, and Psoriasis Disability Index (PDI). Cross-sectional studies with these tools have revealed the substantial burden of dermatological diseases on patients.
Recently, a research group, including the presenter, conducted a qualitative study examining the burden of psoriasis with visible lesions. The study highlighted difficulties in social activities and major life decisions, deeply affecting patients' lives. Based on these findings, the team plans to develop a new QOL tool for quantitative research.
Skin conditions also affect the QOL of patients' families. Though the Family Dermatology Life Quality Index (FDLQI) is available in Japanese, research in this area is limited but expected to advance.
Body image evaluations using the Japanese Cutaneous Body Image Scale (CBIS) showed consistently low scores among female patients with various skin diseases. Notable declines were found in atopic dermatitis, seborrheic dermatitis, and diffuse alopecia. Among atopic dermatitis patients, female scores were lower than male, correlating with emotional impacts on QOL.
Evaluating QOL is essential in both cross-sectional research and intervention outcomes like drug therapies. Using simple questionnaires in routine practice helps healthcare providers understand patient concerns, fostering stronger trust in doctor-patient relationships.